Early outcomes of an integrated hepatology–addiction medicine group medical visit model for alcohol-associated liver disease
Effective management of alcohol-associated liver disease (ALD) requires treatment of coexisting alcohol use disorder (AUD); however, <5% of patients receive evidence-based AUD pharmacotherapy in routine care. We evaluated early outcomes of an interdisciplinary group medical visit (GMV) clinic integrating hepatolo...